Research Archive — Page 31 of 194
-
September 10, 2021
Novel immunotherapy shows robust response for multiple myeloma
Vanderbilt research found that a novel immunotherapy demonstrated robust effectiveness in treating relapsed or refractory multiple myeloma. -
September 8, 2021
VUMC antibodies help neutralize two deadly viruses: study
Vanderbilt researchers have isolated monoclonal antibodies that prevent severe illness and death caused by two emerging and deadly viruses called Nipah and Hendra. -
September 7, 2021
Regulators of fat cell metabolism
Vanderbilt researchers have discovered new details of the regulation of fat cell metabolism, findings that are important for combating obesity. -
September 6, 2021
Medical diagnoses in musicians
Vanderbilt researchers mined electronic health records to find medical diagnoses that are more or less prevalent among musicians, who are present in large numbers in “Music City.” -
September 2, 2021
White matter and schizophrenia
Patients with schizophrenia have functional changes in the white matter of the brain, Vanderbilt researchers have discovered, which may contribute to impaired working memory and processing speed. -
September 2, 2021
Using billing codes to count cancers
The billing codes in electronic health records are useful for counting skin cancers over time — an important metric for cancer risk assessment and prevention. -
September 2, 2021
Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients
Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.